Actelion 2Q Could Provide Positive Surprise, UBS Says
2014-07-16 11:12:49.62 GMT
By Allison Connolly
July 16 (Bloomberg) -- Co. could beat consensus ests. on 2Q
rev., Ebit, EPS as Tracleer ests. are too low, UBS (buy, PT
CHF120) says in note.
* UBS says Tracleer-to-Opsumit switch implied by consensus
could prove overly optimistic
* Sees 2% beat on rev., 19% beat on EPS amd 12% beat on
core Ebit
* Co. reports 2Q results on July 22
* NOTE: June 16, Buy Actelion, Selexipag Data May Transform
Co., BofAML Says
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
To contact the reporter on this story:
Allison Connolly in London at +44-20-3525-7043 or
aconnolly4@bloomberg.net
To contact the editor responsible for this story:
James Ludden at +44-20-7673-2645 or
jludden@bloomberg.net
2014-07-16 11:12:49.62 GMT
By Allison Connolly
July 16 (Bloomberg) -- Co. could beat consensus ests. on 2Q
rev., Ebit, EPS as Tracleer ests. are too low, UBS (buy, PT
CHF120) says in note.
* UBS says Tracleer-to-Opsumit switch implied by consensus
could prove overly optimistic
* Sees 2% beat on rev., 19% beat on EPS amd 12% beat on
core Ebit
* Co. reports 2Q results on July 22
* NOTE: June 16, Buy Actelion, Selexipag Data May Transform
Co., BofAML Says
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
To contact the reporter on this story:
Allison Connolly in London at +44-20-3525-7043 or
aconnolly4@bloomberg.net
To contact the editor responsible for this story:
James Ludden at +44-20-7673-2645 or
jludden@bloomberg.net